1-2 of 2
Andres Llorente
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of PETHEMA LAL-BR-01 Protocol for Low-Risk (LR) Acute Lymphoblastic Leukemia (ALL) In Children

Josep-Maria Ribera, MD, PhD, Albert Oriol, MD, Mireia Morgades, PhD, Pilar Bastida, MD, Olga Garcia, PhD, Alvaro Lasaletta, MD, Jose-Luis Fuster, MD, Elvira Gonzalez-Valentin, MD, Inmaculada Soto, MD, Ana Carbone, MD, Antonio Molines, MD, Izaskun Egurbide, MD, Andres Llorente, MD, Esmeralda Benitez, MD, Luis Madero, MD, PhD, Jose Sanchez de Toledo, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4334.
https://doi.org/10.1182/blood.V116.21.4334.4334
Published: 2010
Journal Articles

Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).

Eva Gonzalez-Barca, Antonio Salar, Joan Bargay, Jose F. Tomas, Miguel A. Canales, Jose M. Moraleda, Maria Jesus Vidal, Secundino Ferrer, Javier Briones, Cristina Estany, Santiago Gardella, Andres Llorente, Dolores Caballero
Journal: Blood
Blood (2007) 110 (11): 3443.
https://doi.org/10.1182/blood.V110.11.3443.3443
Published: 2007